IRVINE, CA--(NewMediaWire- Sep 5, 2017) - Cannabis Science, Inc.
(OTC PINK: CBIS), a U.S. company specializing in the
development of cannabinoid-based medicines, and Free Spirit
Organics Native American Corporation (FSO NAC) are pleased to
announce significantly positive analytical lab testing reports from
its San Joaquin Sovereign Tribal Free Land MBS, Industrial Hemp
Project. Initial analytical reports from the first cut plants
reveals that the strains being used are well within the boundaries
of laws and regulations placed on industrial hemp research projects
of this sort.
The lab results from the 2017 CBIS/FSO NAC MBS001 initial
harvest show values of THC 0.26% and CBD at 5%. This is a critical
initial sign with a ratio of CBD to THC for the strains tested
since these strains were chosen specifically for this reason.
Industrial Hemp has certain regulatory levels of cannabinoids
allowed for legal regulatory status across the country. As compared
to cannabis the cannabinoid levels are much lower in hemp, which
gives it a much lower overdose concern from misuse, abuse, and
public consumption.
A Robust University Infrastructure Focused on Education
and Job Creation
With the Universities at the helm, their main function is the
complete oversight and mind mapping of the Native American
educational and economic development initiative by extensively
using its research and development programs:
1. A primary goal of Raymond C. Dabney University (RCDU), a
school of Law, Business, and Healthcare, is to provide
financially-challenged communities a creative and affordable
opportunity to acquire a quality education beginning with
structured and regulated programs in each of its three main
curriculums along with its entrepreneurial job creation
program.
2. American States University (ASU) is an intricate part of
each land package deal with CBIS/FSO NAC, along with RCDU it
expects to provide full scholarships and additionally subsidized
education packages from its 37 Trade Industries including
alternative medicines to members of the Native American community
and any other challenged individuals to grow with the
initiative.
Our agricultural research programs drive our pharmaceutical and
alternative medicines programs. Our alternative medicines program
is designed to drive our success. Our University Alternative
Medicine program, which grows out of our Agriculture training
program integrates several of our programs and becomes a
comprehensive educational and economic development approach
wherever we create our project. We have the following
infrastructure:
1. ASU has an alternative medicine program that it has been
approved for by the state of California.
a. We will use this program to create curricula for each of the
areas of economic development for the creation of alternative
medicines.
b. We point out each target indication cannabinoid drug
development program will also include covers the development of
alternative medicines.
2. We will create curricula for each area that will
include:
a. Regulatory compliance
b. Company creation and structure
c. Department Management teams and operating staff
d. Planting to Harvest
e. Laboratory testing to formulation creation
f. Manufacturing and distribution
g. Observational and clinical studies
h. Sales and Marketing
The universities are also approved for the development of
curricula in the following areas and we will create programs for
student to learn real-world skills and entrepreneurial
competencies:
1. The development of alternative biofuels,
2. The development of construction materials from
plants,
3. The development of clothing materials,
4. The development of automobile parts, and
5. The development of rope and strings.
For the remainder of 2017, the San Joaquin Sovereign Tribal Free
Land MBS in California, Cannabis Science and FSO NAC will continue
working closely in sync with the Universities chosen for this
substantial research project. The main goals are to vertically
integrate operations to provide a large amount of many jobs
throughout the community in agriculture, education, healthcare
training, construction, and general retail services for the
completion of the 2017, CBIS/FSO NAC MBS001 harvest;
(1) To include Academic and vocational training covering
each applied industry;
(2) Agricultural focused research;
(3) Development of healthcare infrastructure, including
hospitals and health centers;
(4) Pharmaceutical and Alternative Medicines development;
(5) Creation of a sustainable, food security system that is
based on sound agricultural practices that produce sufficient food
for consumption and that are designed to reduce poverty and allow
for real farm-to-table programs;
(6) Development of water management systems; and
(7) Development of waste management systems that reduce the
prevalence of critical risk factors for infectious diseases.
(8) Investment in communications infrastructure, to include
satellite, Internet, mechanical device development, and cellphone
infrastructure; and
(9) Support for policy, regulatory, and jurisdictional
environments, as they pertain to public healthcare, agriculture,
education, job creation, and most important; on the job training
oriented for success.
To date, there have been approximately 25-30 part-time workers
hired so far, and it is expected that another 50-75 people will be
hired before the harvest is completed. The harvesting process is
very labor intensive and very seasonal until the staggering process
has been completed for year around harvesting. At that point, the
Company expects there will be constantly new jobs being created as
the employment requirement will substantially increase to the
number of full-time permanent staff to increase substantially
living in the area to service the full 250 acres for this project
and any required expansions.
A Robust University Education and Job Creation
Infrastructure:
For the remainder of 2017, the San Joaquin Sovereign Tribal Free
Land MBS in California, Cannabis Science and FSO NAC will implement
an economic development plan that is expected to include the
Company and the Universities in vertically-integrated operations to
provide jobs throughout the community for in education, medical
healthcare training, construction, and general services for the
completion of the University industrial hemp commercial research
program scheduled for the 2017, CBIS/FSO NAC MBS001. The initial
laboratory research is quite extensive as plants are harvested and
ready for preliminary dry and wet extraction, with and two-phase
testing. These targets include agricultural research for
alternative medicines, pharmaceutical development program for
medicines targeting critical ailments, wholesale distribution to
physicians and licensed wholesale manufacturers coupled with
extraction research and development for green energy/fuel,
construction materials, clothing fabric, paper manufacturing, food
products, vehicle production parts, and biomass soil, the
industries are many.
About Cannabis Science, Inc.
Cannabis Science, Inc. takes advantage of its unique
understanding of metabolic processes to provide novel treatment
approaches to a number of illnesses for which current treatments
and understanding remain unsatisfactory. Cannabinoids have an
extensive history dating back thousands of years, and currently,
there are a growing number of peer-reviewed scientific publications
that document the underlying biochemical pathways that cannabinoids
modulate. The Company works with leading experts in drug
development, medicinal characterization, and clinical research to
develop, produce, and commercialize novel therapeutic approaches
for the treatment for illnesses caused by infections as well as for
age-related illness. Our initial focus is on cancers, HIV/AIDS, and
neurological conditions. The Company is proceeding with the
research and development of its proprietary drugs as a part of this
initial focus: CS-S/BCC-1, CS-TATI-1, and CS-NEURO-1,
respectively.
Forward-Looking Statements
This Press Release includes forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Act of 1934. A statement containing
words such as "anticipate," "seek," intend," "believe," "estimate,"
"expect," "project," "plan," or similar phrases may be deemed
"forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. Some or all of the events
or results anticipated by these forward-looking statements may not
occur. Factors that could cause or contribute to such differences
include the future U.S. and global economies, the impact of
competition, and the Company's reliance on existing regulations
regarding the use and development of cannabis-based drugs. Cannabis
Science, Inc. does not undertake any duty nor does it intend to
update the results of these forward-looking statements. Safe Harbor
Statement. The Private Securities Litigation Reform Act of 1995
provides a 'safe harbor' for forward-looking statements. Certain of
the statements contained herein, which are not historical facts are
forward looking statements with respect to events, the occurrence
of which involved risks and uncertainties. These forward-looking
statements may be impacted, either positively or negatively, by
various factors. Information concerning potential factors that
could affect the company is detailed from time to time in the
company's reports filed with the Securities and Exchange
Commission.